MetLife, Inc. Logo

MetLife, Inc.

0K0X.L

(0.2)
Stock Price

79,12 USD

0.34% ROA

5.34% ROE

24.63x PER

Market Cap.

51.295.167.000,00 USD

332.4% DER

2.97% Yield

2.36% NPM

MetLife, Inc. Stock Analysis

MetLife, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

MetLife, Inc. Fundamental Stock Analysis
# Analysis Rating
1 Dividend Growth

The company's dividend growth has exhibited a remarkable upward trend over the past three years, consistently delivering higher payouts to shareholders.

2 ROE

Unidentified ROE

3 ROA

Unidentified ROA

4 PBV

Unidentified ROA

5 DER

Unidentified DER

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Graham Number

Unidentified Graham Number

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

MetLife, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

MetLife, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

MetLife, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

MetLife, Inc. Revenue
Year Revenue Growth
2012 68.571.000.000
2013 69.396.000.000 1.19%
2014 73.265.000.000 5.28%
2015 61.257.000.000 -19.6%
2016 60.732.000.000 -0.86%
2017 62.308.000.000 2.53%
2018 67.941.000.000 8.29%
2019 69.620.000.000 2.41%
2020 67.842.000.000 -2.62%
2021 71.080.000.000 4.56%
2022 69.898.000.000 -1.69%
2023 63.464.000.000 -10.14%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

MetLife, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

MetLife, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

MetLife, Inc. EBITDA
Year EBITDA Growth
2012 -4.271.000.000
2013 -2.894.000.000 -47.58%
2014 -1.403.000.000 -106.27%
2015 -1.315.000.000 -6.69%
2016 -1.455.000.000 9.62%
2017 1.525.000.000 195.41%
2018 -1.329.000.000 214.75%
2019 -1.249.000.000 -6.41%
2020 -1.138.000.000 -9.75%
2021 -1.140.000.000 0.18%
2022 -1.141.000.000 0.09%
2023 1.836.000.000 162.15%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

MetLife, Inc. Gross Profit
Year Gross Profit Growth
2012 68.571.000.000
2013 69.396.000.000 1.19%
2014 73.265.000.000 5.28%
2015 61.257.000.000 -19.6%
2016 60.732.000.000 -0.86%
2017 62.308.000.000 2.53%
2018 67.941.000.000 8.29%
2019 69.620.000.000 2.41%
2020 67.842.000.000 -2.62%
2021 71.080.000.000 4.56%
2022 69.898.000.000 -1.69%
2023 63.464.000.000 -10.14%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

MetLife, Inc. Net Profit
Year Net Profit Growth
2012 1.154.000.000
2013 3.244.000.000 64.43%
2014 6.190.000.000 47.59%
2015 3.891.000.000 -59.09%
2016 3.481.000.000 -11.78%
2017 4.893.000.000 28.86%
2018 4.982.000.000 1.79%
2019 5.721.000.000 12.92%
2020 5.191.000.000 -10.21%
2021 6.353.000.000 18.29%
2022 2.354.000.000 -169.88%
2023 1.688.000.000 -39.45%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

MetLife, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 1
2013 3 50%
2014 5 60%
2015 3 -66.67%
2016 3 0%
2017 5 25%
2018 5 0%
2019 6 33.33%
2020 6 -20%
2021 7 28.57%
2022 3 -250%
2023 2 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

MetLife, Inc. Free Cashflow
Year Free Cashflow Growth
2012 17.160.000.000
2013 16.131.000.000 -6.38%
2014 16.376.000.000 1.5%
2015 14.052.000.000 -16.54%
2016 14.774.000.000 4.89%
2017 12.283.000.000 -20.28%
2018 11.738.000.000 -4.64%
2019 13.786.000.000 14.86%
2020 11.639.000.000 -18.45%
2021 12.596.000.000 7.6%
2022 13.204.000.000 4.6%
2023 3.475.000.000 -279.97%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

MetLife, Inc. Operating Cashflow
Year Operating Cashflow Growth
2012 17.160.000.000
2013 16.131.000.000 -6.38%
2014 16.376.000.000 1.5%
2015 14.052.000.000 -16.54%
2016 14.774.000.000 4.89%
2017 12.283.000.000 -20.28%
2018 11.738.000.000 -4.64%
2019 13.786.000.000 14.86%
2020 11.639.000.000 -18.45%
2021 12.596.000.000 7.6%
2022 13.204.000.000 4.6%
2023 3.475.000.000 -279.97%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

MetLife, Inc. Capital Expenditure
Year Capital Expenditure Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

MetLife, Inc. Equity
Year Equity Growth
2012 64.958.000.000
2013 62.983.000.000 -3.14%
2014 72.659.000.000 13.32%
2015 68.496.000.000 -6.08%
2016 67.702.000.000 -1.17%
2017 58.870.000.000 -15%
2018 52.958.000.000 -11.16%
2019 66.382.000.000 20.22%
2020 74.817.000.000 11.27%
2021 67.749.000.000 -10.43%
2022 27.287.000.000 -148.28%
2023 25.895.000.000 -5.38%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

MetLife, Inc. Assets
Year Assets Growth
2012 836.781.000.000
2013 885.296.000.000 5.48%
2014 902.337.000.000 1.89%
2015 877.933.000.000 -2.78%
2016 898.764.000.000 2.32%
2017 719.892.000.000 -24.85%
2018 687.538.000.000 -4.71%
2019 740.463.000.000 7.15%
2020 795.146.000.000 6.88%
2021 759.708.000.000 -4.66%
2022 666.611.000.000 -13.97%
2023 652.120.000.000 -2.22%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

MetLife, Inc. Liabilities
Year Liabilities Growth
2012 771.823.000.000
2013 41.014.000.000 -1781.85%
2014 75.368.000.000 45.58%
2015 75.047.000.000 -0.43%
2016 69.576.000.000 -7.86%
2017 72.046.000.000 3.43%
2018 67.032.000.000 -7.48%
2019 69.984.000.000 4.22%
2020 77.095.000.000 9.22%
2021 75.174.000.000 -2.56%
2022 76.165.000.000 1.3%
2023 626.225.000.000 87.84%

MetLife, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
85.19
Net Income per Share
2.81
Price to Earning Ratio
24.63x
Price To Sales Ratio
0.8x
POCF Ratio
4.72
PFCF Ratio
4.63
Price to Book Ratio
2.04
EV to Sales
0.57
EV Over EBITDA
193.53
EV to Operating CashFlow
3.29
EV to FreeCashFlow
3.29
Earnings Yield
0.04
FreeCashFlow Yield
0.22
Market Cap
51,30 Bil.
Enterprise Value
36,38 Bil.
Graham Number
46.42
Graham NetNet
-811.22

Income Statement Metrics

Net Income per Share
2.81
Income Quality
4.79
ROE
0.07
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0.73
EBT Per Ebit
1.21
Ebit per Revenue
0.03
Effective Tax Rate
0.26

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
1
Operating Profit Margin
0.03
Pretax Profit Margin
0.03
Net Profit Margin
0.02

Dividends

Dividend Yield
0.03
Dividend Yield %
2.97
Payout Ratio
0.83
Dividend Per Share
2.06

Operating Metrics

Operating Cashflow per Share
14.69
Free CashFlow per Share
14.69
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.02
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
19,79
Book Value per Share
34,05
Tangible Book Value per Share
-3.92
Shareholders Equity per Share
34.05
Interest Debt per Share
113.18
Debt to Equity
3.32
Debt to Assets
0.13
Net Debt to EBITDA
-79.32
Current Ratio
677.82
Tangible Asset Value
-2,95 Bil.
Net Current Asset Value
-611,31 Bil.
Invested Capital
3.32
Working Capital
14,89 Bil.
Intangibles to Total Assets
0.04
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
1.66

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

MetLife, Inc. Dividends
Year Dividends Growth
2018 1
2022 0 0%
2023 2 100%

MetLife, Inc. Profile

About MetLife, Inc.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

CEO
Mr. Michel Abbas Khalaf
Employee
45.000
Address
200 Park Avenue
New York, 10166-0188

MetLife, Inc. Executives & BODs

MetLife, Inc. Executives & BODs
# Name Age
1 Mr. John Dennis McCallion CPA
Executive Vice President, Chief Financial Officer & Head of Investment Management
70
2 Ms. Susan M. Podlogar M.B.A.
Executive Vice President & Chief HR Officer
70
3 Mr. Pawan Singh Verma
Executive Vice President & Chief Information Officer
70
4 Mr. Michael Kevin Farrell
EVice President, Head - Independent Distribution - St Louis-Based GenAmerica Financial & MetLife Investors Group
70
5 Mr. Michel Abbas Khalaf
Chief Executive Officer, President & Director
70
6 Ms. Tamara Lynn Schock C.A., CPA
Executive Vice President & Chief Accounting Officer
70
7 Mr. Ramy Tadros
President of U.S. Business & Head of MetLife Holdings
70
8 Mr. Michael Roberts
Executive Vice President & Chief Marketing Officer
70
9 Mr. Bill Pappas
Executive Vice President and Head of Global Technology & Operations
70
10 Mr. John Arthur Hall
Senior Vice President & Head of Investor Relations
70

MetLife, Inc. Competitors

Eaton Corporation plc Logo
Eaton Corporation plc

0Y3K.L

(0.2)
Public Storage Logo
Public Storage

0KS3.L

(0.0)
The Southern Company Logo
The Southern Company

0L8A.L

(0.0)